Internal Medicine
Mounjaro (Tirzepatide): How It Works, Uses, Side Effects, Safety, and Jordan Warning
Reviewed by the JordanMedHub Medical Editorial Team · 8/29/2026
Quick Answer
A medically responsible overview of Mounjaro (tirzepatide) — how it works, what it's approved for, and key things to discuss with your doctor.
In this article
Mounjaro is the brand name for tirzepatide, a prescription injection approved for managing type 2 diabetes. It works differently from older diabetes medications, and its effect on appetite and weight has made it one of the most talked-about medications in this class.
How Mounjaro Works
Tirzepatide is a dual agonist — it activates both the GLP-1 and GIP hormone receptors, rather than GLP-1 alone. Both hormones play a role in regulating appetite, insulin release, and how the body stores fat. Activating both together is believed to produce a stronger effect on appetite and blood sugar than activating GLP-1 alone.
Established medical practice
Mounjaro (tirzepatide) is approved by major regulators for type 2 diabetes. In the European Union the same product is also authorised for weight management in adults with obesity, or with overweight plus a weight-related condition (European Medicines Agency); in the United States, tirzepatide for weight management is sold under a separate brand name.
How It's Taken
What Regulators Have Approved It For
| Use | European Medicines Agency wording |
|---|---|
| Type 2 diabetes | Adults, adolescents and children aged 10+ whose diabetes is not controlled well enough; alone or with other diabetes medicines |
| Weight management | Adults with obesity (BMI 30 or more), or overweight (BMI 27–29.9) with a weight-related condition such as high blood pressure, abnormal cholesterol or sleep apnea |
Approval in one country does not guarantee a product is registered or stocked in another. JordanMedHub does not publish verified information on Mounjaro's price or pharmacy availability in Jordan.
Mounjaro is given as a once-weekly injection under the skin, with the starting dose kept low and increased gradually over time under a doctor's supervision — this gradual approach is standard for this medication class and helps the body adjust while managing side effects. Your doctor and pharmacist will give you specific instructions for your prescription; this article describes the general pattern only.
Dosing Day, Missed Doses, and Injection Sites
The NHS patient information says to inject once a week into fatty areas — the abdomen, thigh or upper arm — on the same day each week, with at least three days between doses. For a missed dose, its guidance is to inject as soon as you remember if it is 4 days or less since the dose was due, and to skip it and carry on normally if it is more than 4 days. Always follow the leaflet supplied with your own pen, since instructions can differ by country and product.
Weight Loss and Tirzepatide
Because tirzepatide reduces appetite, many people taking it for diabetes also lose weight. Whether tirzepatide is labeled for diabetes, for weight management, or both depends on the country: the EU authorises Mounjaro for both, while in the US the weight-management version has its own brand. If your goal is primarily weight loss rather than diabetes management, ask your doctor which approved product and labeling apply to you.
Emerging trend — evidence still developing
A completed head-to-head randomized controlled trial (SURMOUNT-5) comparing tirzepatide-based and semaglutide-based medications for weight management found that tirzepatide produced significantly greater average weight loss than semaglutide over 72 weeks — but individual results vary considerably, and the right choice is still a decision to make with a doctor, not based on averages alone.
What the Head-to-Head Trial Actually Found
SURMOUNT-5 randomized 751 adults with obesity but without diabetes to the maximum tolerated dose of tirzepatide or of semaglutide for 72 weeks. Average body-weight change was −20.2% with tirzepatide versus −13.7% with semaglutide, and waist circumference fell about 18.4 cm versus 13.0 cm. The most common side effects in both groups were digestive, mostly mild to moderate and mainly during dose increases. These are group averages from one open-label trial — they say nothing certain about what you will lose, and they apply to people without diabetes.
Side Effects and When to Get Help
The EMA lists nausea, vomiting, abdominal pain, constipation and diarrhea as very common; low blood sugar is also very common when Mounjaro is used with insulin or a sulfonylurea. For digestive symptoms, see our guides on constipation and GLP-1 side effects.
Seek urgent medical care
Get urgent medical help for signs of an allergic reaction, severe or persistent stomach pain (possible pancreatitis), pain in the upper right abdomen with fever or yellowing skin (possible gallbladder problem), or symptoms of very low blood sugar such as shakiness, sweating and confusion.
Pregnancy, Contraception, and Alcohol
The NHS advises stopping tirzepatide at least four weeks before trying to conceive, and using an additional barrier method of contraception for four weeks after starting and after each dose increase, because it can make some contraceptive pills less effective. It also advises avoiding alcohol, which can worsen nausea and vomiting. Anyone allergic to tirzepatide or other GLP-1 medicines, or who has had pancreatitis, should not use it.
Fake Mounjaro: A Jordan-Specific Warning
Jordan's drug regulator, the JFDA, publicly warned (as reported by Jordanian media in May 2026) that oral "Mounjaro" pills sold through social media in Jordan are counterfeit — unregistered, of unverified composition, and not the same product as the real medication, whose only approved form is the injection. It has also stated that selling medicines online is prohibited in Jordan. Our complete GLP-1 guide covers this in full; the Jordan drug regulator (JFDA) is the source to check.
Related Guides
GLP-1 muscle loss · what to eat on GLP-1 · weight-loss plateau · stopping GLP-1 injections · bariatric surgery vs GLP-1 · BMI calculator · type 2 diabetes · endocrinology
Who Might Be a Candidate
Mounjaro is prescribed based on a full review of your medical history, current medications, and health goals. See our eligibility and medical supervision guide for the general criteria doctors consider, and our side effects and risks guide for what to watch for.
How It Compares
If you're deciding between Mounjaro and other options like Ozempic or Wegovy, our full comparison guide walks through the practical differences.
Sources
- Mounjaro — European Medicines Agency (EPAR)
- Tirzepatide (Mounjaro) — NHS medicines
- FDA approves new medication for chronic weight management (Zepbound) — U.S. FDA
- Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5) — PubMed
- Jordan Food and Drug Administration (JFDA)
Disclaimer
This article is for general education only. Mounjaro is a prescription medication — only a doctor who knows your full medical history can determine if it's appropriate for you, and at what dose.
Frequently Asked Questions
Is Mounjaro the same as Zepbound?
They contain the same active ingredient, tirzepatide. Mounjaro is authorised for type 2 diabetes and, in the EU, also for weight management; in the US, tirzepatide for weight management is sold as Zepbound. Which product is registered or available where you live can differ — a doctor or pharmacist can tell you.
How quickly does Mounjaro work?
Effects on appetite and blood sugar can begin within the first weeks, but meaningful weight change typically develops gradually over months, alongside dose adjustments made by your doctor.
Can I take Mounjaro if I don't have diabetes?
It depends on the specific labeling and your doctor's judgment — some patients without diabetes are prescribed a tirzepatide-based medication for weight management specifically. This should always be a decision made with a doctor, not a self-directed choice.
What should I do if I miss a Mounjaro dose?
Follow the leaflet with your pen. The NHS patient information says to inject as soon as you remember if it is 4 days or less since the dose was due, and to skip it and resume your usual day if it is more than 4 days.
Is Mounjaro safe to buy online or as pills in Jordan?
No. Jordan's drug regulator, the JFDA, has warned that oral "Mounjaro" pills sold through social media are counterfeit and unregistered, and has stated that selling medicines online is prohibited. The only approved form is the injection, prescribed by a doctor.
What are the most common Mounjaro side effects?
According to the European Medicines Agency: nausea, vomiting, abdominal pain, constipation and diarrhea, plus low blood sugar when used with insulin or a sulfonylurea. Severe or persistent stomach pain, signs of an allergic reaction or very low blood sugar need urgent medical help.
Written by JordanMedHub Medical Editorial Team
Updated
Need to speak with a specialist?
Find a doctor near you to discuss your symptoms and treatment options.
Find a doctor